Biohaven Ltd.
BHVN
$19.84
-$3.56-15.21%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -846.42M | -804.34M | -746.61M | -517.18M | -408.17M |
| Total Depreciation and Amortization | 7.86M | 7.29M | 6.83M | 6.71M | 6.91M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 239.30M | 256.35M | 263.27M | 92.70M | 44.92M |
| Change in Net Operating Assets | 16.81M | 14.11M | -3.63M | 61.05M | 24.61M |
| Cash from Operations | -582.45M | -526.59M | -480.13M | -356.72M | -331.73M |
| Capital Expenditure | -4.05M | -4.47M | -5.11M | -2.75M | -3.05M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 391.00K | 391.00K | 391.00K | 391.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -241.32M | -157.13M | -4.55M | 167.28M | 132.88M |
| Cash from Investing | -244.97M | -161.21M | -9.27M | 164.92M | 129.83M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 677.67M | 642.80M | 566.44M | 250.12M | 248.25M |
| Repurchase of Common Stock | -- | -- | -- | -332.00K | -332.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 108.00K | 7.36M | -36.32M | -61.13M | -36.01M |
| Cash from Financing | 677.77M | 650.16M | 530.13M | 188.66M | 211.91M |
| Foreign Exchange rate Adjustments | 75.00K | -323.00K | -363.00K | -518.00K | -497.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -149.58M | -37.97M | 40.37M | -3.66M | 9.52M |